The Green Road (Enright novel)

Valens Secures Sales Licence for Greater Toronto Area Beverage Facility

Retrieved on: 
Wednesday, November 2, 2022

KELOWNA, BC, Nov. 2, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the "Company" or "Valens") (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced it has received a sales licence amendment from Health Canada for its Pommies manufacturing facility located in the Greater Toronto Area (the "GTA Facility") to sell micro processed cannabis products directly to provincial distributors.

Key Points: 
  • KELOWNA, BC, Nov. 2, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the "Company" or "Valens") (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced it has received a sales licence amendment from Health Canada for its Pommies manufacturing facility located in the Greater Toronto Area (the "GTA Facility") to sell micro processed cannabis products directly to provincial distributors.
  • Prior to this announcement, Valens leveraged its British Columbia sales licence to sell into the provincial distributors which created additional cost and complexity in our supply chain.
  • "Since the opening of our facility in November 2021 we have already seen an increase in our beverage margins," said Tyler Robson, Chief Executive Officer of Valens.
  • Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

The Valens Company to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2022

Retrieved on: 
Wednesday, July 6, 2022

KELOWNA, BC, July 6, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company" "The Valens Company" or "Valens"),a leading manufacturer of cannabis products, is pleased to announce it will issue its second quarter 2022 financial results for the period ended May 31, 2022, on Wednesday, July 13, 2022, after market close.

Key Points: 
  • KELOWNA, BC, July 6, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company" "The Valens Company" or "Valens"),a leading manufacturer of cannabis products, is pleased to announce it will issue its second quarter 2022 financial results for the period ended May 31, 2022, on Wednesday, July 13, 2022, after market close.
  • The Company will host a conference call the following day, Thursday, July 14, 2022, at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time to discuss the financial results and business outlook.
  • The call will be available via webcast on the Valens investor page of the Company website at https://thevalenscompany.com/investors/ or at this link.
  • A replay of the call will be available on the Valens investor page approximately two hours after the conference call has ended.

The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2022

Retrieved on: 
Thursday, April 7, 2022

The Company will host a conference call the following day, Thursday, April 14, 2022, at 11:00 AM Eastern Time / 8:00 AM Pacific Time to discuss the financial results and business outlook.

Key Points: 
  • The Company will host a conference call the following day, Thursday, April 14, 2022, at 11:00 AM Eastern Time / 8:00 AM Pacific Time to discuss the financial results and business outlook.
  • The call will be available via webcast on the Valens investor page of the Company website at https://thevalenscompany.com/investors/ or at this link .
  • A replay of the call will be available on the Valens investor page approximately two hours after the conference call has ended.
  • Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

The Valens Company to Hold Conference Call to Discuss Financial Results for the Fourth Quarter and Fiscal Year 2021

Retrieved on: 
Thursday, February 17, 2022

The call will be available via webcast on the Valens investor page of the Company website at https://thevalenscompany.com/investors/ or at this link .

Key Points: 
  • The call will be available via webcast on the Valens investor page of the Company website at https://thevalenscompany.com/investors/ or at this link .
  • A replay of the call will be available on the Valens investor page approximately two hours after the conference call has ended.
  • The Valens Company is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world.
  • Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

Green Roads Launches 'Own the Day' Brand Campaign

Retrieved on: 
Wednesday, January 19, 2022

The campaign celebrates Green Roads' products and their ability to help consumers with common health and wellness challenges such as stress, sleep, muscle and joint pain, relaxation, and focus.

Key Points: 
  • The campaign celebrates Green Roads' products and their ability to help consumers with common health and wellness challenges such as stress, sleep, muscle and joint pain, relaxation, and focus.
  • Green Roads also relaunched its DTC e-commerce experience to carry the Own the Day messaging and prominently feature the solutions and personas featured in the campaign.
  • "With this campaign, we want to position Green Roads as a trusted partner with a portfolio of products aimed at helping consumers achieve their personal health and wellness objectives."
  • "Own the Day"was created in partnership with Known , the agency of record for media and creative for Green Roads.

The Valens Company Announces Two Strategic Agreements with PMI Mexico

Retrieved on: 
Tuesday, December 21, 2021

At the conclusion of the trial, Valens will be the sole manufacturer and global distributor in collaboration with PMI.

Key Points: 
  • At the conclusion of the trial, Valens will be the sole manufacturer and global distributor in collaboration with PMI.
  • Under the second agreement, Valens will manufacture and distribute CBD-infused and uninfused Predilife products globally while PMI will be responsible for distribution of the Predilife products in Mexico.
  • "The relationship we have built with PMI Mexico marks an important milestone for Valens' international expansion and the beginning of our Central and Latin America strategy," said Tyler Robson, CEO, Chair & Co-founder of The Valens Company.
  • Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

The Valens Company Secures CAD$40 Million Term Loan

Retrieved on: 
Thursday, December 16, 2021

KELOWNA, BC, Dec. 16, 2021 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announces that it has entered into a secured non-revolving term loan (the "Loan Agreement") with 2361380 Ontario Limited , a private institutional lender, for an aggregate principal amount up to CAD$40 million (the "Loan").

Key Points: 
  • KELOWNA, BC, Dec. 16, 2021 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announces that it has entered into a secured non-revolving term loan (the "Loan Agreement") with 2361380 Ontario Limited , a private institutional lender, for an aggregate principal amount up to CAD$40 million (the "Loan").
  • This CAD$40 million Term Loan reflects the unique value proposition that Valens has created in the market, as well as the continued confidence from our management, board, and shareholders in the continued execution of our business plan."
  • The Valens Company is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world.
  • Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

The Valens Company to Begin Trading on Nasdaq Capital Market

Retrieved on: 
Wednesday, December 8, 2021

Common Shares are Expected to Begin Trading Tomorrow on December 9, 2021, Under Ticker "VLNS"

Key Points: 
  • Common Shares are Expected to Begin Trading Tomorrow on December 9, 2021, Under Ticker "VLNS"
    KELOWNA, BC, Dec. 8, 2021 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announces that the Company's application to list its common shares on Nasdaq Capital Market ("Nasdaq") has been approved.
  • The Company's common shares (the "Common Shares") are expected to commence trading on Nasdaq under the symbol "VLNS" on December 9, 2021.
  • The Company's shares will continue to trade on the OTCQX under the symbol "VLNCD" until trading on Nasdaq commences.
  • Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

The Valens Company Completes Acquisition of Leading, Premium Craft Licensed Producer, Citizen Stash Cannabis Corp.

Retrieved on: 
Monday, November 8, 2021

Under the terms of the Arrangement, Citizen Stash shareholders are entitled to 0.1620 of a Valens common share ("Valens Share") for each Citizen Stash Common Share held.

Key Points: 
  • Under the terms of the Arrangement, Citizen Stash shareholders are entitled to 0.1620 of a Valens common share ("Valens Share") for each Citizen Stash Common Share held.
  • Lastly, Hillcrest Merchant Partners Inc. ("Hillcrest") received 1,519,306 Citizen Stash Common Shares that entitled Hillcrest to 0.1620 of a Valens Share per Citizen Stash Common Share.
  • Going forward as a combined company, Citizen Stash and Valens are well-positioned to be the leading cannabis company in Canada and beyond.
  • About Citizen Stash Cannabis Corp.
    Citizen Stash is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of cannabis, based in Mission, BC.

Aurora Announces Manufacturing Agreement with The Valens Company

Retrieved on: 
Thursday, October 28, 2021

EDMONTON, AB, Oct. 28, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced a manufacturing agreement with The Valens Company Inc. ("The Valens Company" or "Valens") a leading manufacturer of cannabis products, to manufacture a new seasonal offering in the mint category.

Key Points: 
  • EDMONTON, AB, Oct. 28, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced a manufacturing agreement with The Valens Company Inc. ("The Valens Company" or "Valens") a leading manufacturer of cannabis products, to manufacture a new seasonal offering in the mint category.
  • "Valens' exceptional manufacturing capabilities complement our product line up this upcoming holiday season.
  • The Company's brandportfolio includes Aurora, Aurora Drift , San Rafael '71 , Daily Special ,MedReleaf,CanniMed, Whistler , Reliva and KG7 CBD .
  • The Valens Company is a leading cannabis consumer products company, with significant expertise in manufacturing cannabinoid based products and a mission to bring the benefits of cannabis to the world.